Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 256

1.

Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM; MTN-020/ASPIRE Study..

AIDS. 2017 May 15;31(8):1159-1167. doi: 10.1097/QAD.0000000000001452.

PMID:
28441175
2.

Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.

Patel RC, Baeten JM, Heffron R, Hong T, Davis NL, Nanda K, Coombs RW, Lingappa JR, Bukusi EA, Hurst S, Thomas KK, Kourtis AP, Mugo N; Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams..

J Acquir Immune Defic Syndr. 2017 May 1;75(1):91-96. doi: 10.1097/QAI.0000000000001339.

PMID:
28399558
3.

A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples.

Bochner AF, Baeten JM, Rustagi AS, Nakku-Joloba E, Lingappa JR, Mugo NR, Bukusi EA, Kapiga S, Delany-Moretlwe S, Celum C, Barnabas RV; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams..

Sex Transm Infect. 2017 Apr 4. pii: sextrans-2016-053034. doi: 10.1136/sextrans-2016-053034. [Epub ahead of print]

PMID:
28377421
4.

Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya.

Ngure K, Heffron R, Mugo N, Thomson KA, Irungu E, Njuguna N, Mwaniki L, Celum C, Baeten JM.

J Int AIDS Soc. 2017 Feb 8;20(1):1-8. doi: 10.7448/IAS.20.1.21234.

PMID:
28362073
5.

Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.

Ngure K, Kimemia G, Dew K, Njuguna N, Mugo N, Celum C, Baeten JM, Heffron R.

J Int AIDS Soc. 2017 Mar 8;20(Suppl 1):52-58. doi: 10.7448/IAS.20.2.21309.

PMID:
28361508
6.

HSV-2 acquisition among HIV-1 infected adults treated with tenofovir as part of combination antiretroviral therapy: Results from the ACTG A5175 PEARLS study.

Celum C, Hong T, Cent A, Donnell D, Morrow R, Baeten JM, Firnhaber C, Grinsztejn B, Hosseinipour MC, Lalloo U, Nyirenda M, Riviere C, Sanchez J, Santos B, Supparatpinyo K, Hakim J, Kumarasamy N, Campbell TB; ACTG PEARLS/A5175 team..

J Infect Dis. 2017 Jan 30. doi: 10.1093/infdis/jix029. [Epub ahead of print]

PMID:
28329270
7.

"It's inside my body and it's mine".

Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, Bekker LG, Etima J, Nakyanzi T, Mayo AJ, Katz A, Laborde N, Grossman CI, Soto-Torres L, Palanee-Phillips T, Baeten JM; MTN-020ASPIRE Study..

AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452. [Epub ahead of print]

PMID:
28323754
8.

Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.

Thomson KA, Haberer JE, Marzinke M, Mujugira A, Hendrix C, Celum C, Ndase P, Ronald A, Bangsberg DR, Baeten JM; Partners PrEP Study Team..

J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001356. [Epub ahead of print]

PMID:
28291050
9.

Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol.

Buttolph J, Inwani I, Agot K, Cleland CM, Cherutich P, Kiarie JN, Osoti A, Celum CL, Baeten JM, Nduati R, Kinuthia J, Hallett TB, Alsallaq R, Kurth AE.

JMIR Res Protoc. 2017 Mar 8;6(3):e22. doi: 10.2196/resprot.5833.

10.

Dapivirine Vaginal Ring for HIV-1 Prevention.

Baeten JM, Brown ER, Hillier SL.

N Engl J Med. 2017 Mar 9;376(10):995-6. doi: 10.1056/NEJMc1616546. No abstract available.

11.

Notch Signaling in Vascular Smooth Muscle Cells.

Baeten JT, Lilly B.

Adv Pharmacol. 2017;78:351-382. doi: 10.1016/bs.apha.2016.07.002. Epub 2016 Aug 26.

PMID:
28212801
12.

Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.

Lund JM, Broliden K, Pyra MN, Thomas KK, Donnell D, Irungu E, Muwonge TR, Mugo N, Manohar M, Jansson M, Mackelprang R, Marzinke MA, Baeten JM, Lingappa JR.

J Virol. 2017 Jan 18;91(3). pii: e02074-16. doi: 10.1128/JVI.02074-16. Print 2017 Feb 1. No abstract available.

13.

Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?

Smith JA, Heffron R, Butler AR, Celum C, Baeten JM, Hallett TB.

Contraception. 2017 Apr;95(4):424-430. doi: 10.1016/j.contraception.2016.12.003. Epub 2016 Dec 28.

14.

"Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.

Patel RC, Stanford-Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, Bukusi EA, Baeten JM, Brown JM.

J Int AIDS Soc. 2016 Dec 12;19(1):21134. doi: 10.7448/IAS.19.1.21134. eCollection 2016.

15.

Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study.

Patel RC, Odoyo J, Anand K, Stanford-Moore G, Wakhungu I, Bukusi EA, Baeten JM, Brown JM.

PLoS One. 2016 Dec 8;11(12):e0168057. doi: 10.1371/journal.pone.0168057. eCollection 2016.

16.

Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.

Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R; Partners Demonstration Project Team..

J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S15-S22.

17.

Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis.

Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, Baeten JM, Celum C, Hendrix CW.

J Clin Pharmacol. 2017 May;57(5):606-615. doi: 10.1002/jcph.843. Epub 2016 Dec 6.

PMID:
27922719
18.

Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships.

Mujugira A, Celum C, Ngure K, Thomas KK, Katabira E, Baeten JM; Partners PrEP Study Team..

Sex Transm Dis. 2017 Jan;44(1):57-61.

PMID:
27898566
19.

Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.

Andersen-Nissen E, Chang JT, Thomas KK, Adams D, Celum C, Sanchez J, Coombs RW, McElrath MJ, Baeten JM.

Sex Transm Dis. 2016 Dec;43(12):761-764.

PMID:
27832025
20.

Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.

Kourtis AP, Wiener J, King CC, Heffron R, Mugo NR, Nanda K, Pyra M, Donnell D, Celum C, Lingappa JR, Baeten JM; Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams..

J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):38-43.

Supplemental Content

Loading ...
Support Center